Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
15%
OVERLAP
BY WEIGHT
8
# OF OVERLAPPING
HOLDINGS
LFSC
34
HOLDINGS
25%
ALSO IN PSCH
PSCH
69
HOLDINGS
12%
ALSO IN LFSC
SECTOR DRIFT (LFSC minus PSCH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in LFSC |
Weight in PSCH |
Overlap | |
|---|---|---|---|---|
 |
RADNET INC | 3.6% | 3.4% | 3.4% |
|
CORCEPT THERAPEUTICS INC | 2.8% | 5.2% | 2.8% |
|
TRANSMEDICS GROUP, INC. | 5.3% | 2.5% | 2.5% |
|
MERIT MEDICAL SYSTEMS INC | 2.2% | 3.1% | 2.2% |
|
ACADIA PHARMACEUTICALS INC | 1.5% | 1.7% | 1.5% |
LFSC Overweight Relative to PSCH
|
TRAVERE THERAPEUTICS, INC. | 7.3% |
|
GUARDANT HEALTH, INC. | 5.7% |
 |
LIVANOVA PLC | 5.3% |
|
COGENT BIOSCIENCES INC | 4.7% |
|
NEKTAR THERAPEUTICS | 4.5% |
|
BRIDGEBIO PHARMA, INC. | 4.0% |
|
SOLENO THERAPEUTICS INC | 4.0% |
|
WAVE LIFE SCIENCES LTD. | 3.7% |
|
MADRIGAL PHARMACEUTICALS, INC. | 3.4% |
|
UNITED THERAPEUTICS CORP | 3.2% |
LFSC Underweight Relative to PSCH
|
TELEFLEX INC | -3.6% |
 |
ALKERMES PLC | -3.2% |
|
GLAUKOS CORP | -3.1% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.1% |
|
TG THERAPEUTICS INC | -3.1% |
|
KRYSTAL BIOTECH, INC. | -2.9% |
|
PROTAGONIST THERAPEUTICS, INC. | -2.4% |
|
CORCEPT THERAPEUTICS INC | -2.3% |
|
LIGAND PHARMACEUTICALS-CL B | -2.2% |
|
ADMA BIOLOGICS, INC. | -2.2% |